Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Employee and Director Benefits

v3.20.2
Note 7 - Employee and Director Benefits
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]

NOTE 7 - EMPLOYEE AND DIRECTOR BENEFITS

 

Stock Options

 

The Company has a stock-based compensation plan as described below. The compensation cost that has been charged to earnings for the plan was $340,000 and $969,000 for the three and nine months ended September 30, 2020 and $294,000 and $781,000 for the three and nine months ended September 30, 2019.

 

The Company’s 2009 Amended and Restated Stock Incentive Plan authorizes the grant of up to 5,550,000 shares and allows for the issuance of Stock Appreciation Rights, Restricted Stock, Stock Options, Performance Shares or Performance Units. The plan allows for the grant of incentive stock options and non-qualified stock options, and option awards are granted with an exercise price equal to the market value of the Company’s common stock at the date of grant. The maximum term of the options granted under the plan is ten years.

 

The Company estimates the fair value of each stock option award using a Black-Scholes-Merton valuation model that uses the assumptions noted in the following table. Expected volatility is based on historical volatilities of the Company’s common stock. The expected term for options granted is based on the short-cut method and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

 

   

2019

 

Expected volatility

    40.00

%

Expected dividends

    1.74

%

Expected term (in years)

    6.7  

Risk-free rate

    2.56

%

 

There were no grants of stock options during the nine months ended September 30, 2020. The weighted average grant-date fair value of options granted during the nine months ended September 30, 2019 was $12.60.

 

The following table summarizes stock option activity during the nine months ended September 30, 2020 and September 30, 2019:

 

                   

Weighted

         
           

Weighted

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
           

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term (years)

   

Value

 
                           

(In Thousands)

 

Nine Months Ended September 30, 2020:

                               

Outstanding at January 1, 2020

    965,248     $ 15.19       4.9     $ 21,911  

Granted

    -       -       -       -  

Exercised

    (279,300 )     11.36       3.2       6,330  

Forfeited

    (18,000 )     30.79       6.4       58  

Outstanding at September 30, 2020

    667,948       16.37       4.5     $ 11,720  
                                 

Exercisable at September 30, 2020

    209,200     $ 12.41       3.2     $ 4,425  
                                 

Nine Months Ended September 30, 2019:

                               

Outstanding at January 1, 2019

    1,238,748     $ 13.02       5.2     $ 23,355  

Granted

    10,500       34.44       9.4       (14 )

Exercised

    (239,300 )     7.02       2.3       6,162  

Forfeited

    (20,200 )     24.88       6.5       167  

Outstanding at September 30, 2019

    989,748       14.46       5.0     $ 18,603  
                                 

Exercisable at September 30, 2019

    278,000     $ 7.36       3.1     $ 7,261  

 

As of September 30, 2020, there was $815,000 of total unrecognized compensation cost related to non-vested stock options. The cost is expected to be recognized on the straight-line method over the next 0.9 years.

 

Restricted Stock

 

The Company periodically grants restricted stock awards that vest upon service conditions. Dividend payments are made during the vesting period. The value of restricted stock is determined to be the current value of the Company’s stock, and this total value will be recognized as compensation expense over the vesting period. As of September 30, 2020, there was $1.8 million of total unrecognized compensation cost related to non-vested restricted stock. The cost is expected to be recognized evenly over the remaining 2.9 years of the restricted stock’s vesting period.

 

The following table summarizes restricted stock activity during the nine months ended September 30, 2020 and 2019, respectively:

 

   

Shares

   

Weighted

Average Grant

Date Fair Value

 

Nine Months Ended September 30, 2020:

               

Non-vested at January 1, 2020

    71,290     $ 31.53  

Granted

    29,067       33.20  

Vested

    (19,928 )     23.64  

Forfeited

    -       -  

Non-vested at September 30, 2020

    80,429       34.09  
                 

Nine Months Ended September 30, 2019:

               

Non-vested at January 1, 2019

    56,576     $ 29.94  

Granted

    21,274       34.08  

Vested

    (5,200 )     20.31  

Forfeited

    (2,500 )     38.17  

Non-vested at September 30, 2019

    70,150       31.62